Naveris developed a brand new, non-invasive testing technology to detect cancers related to human papillomavirus (HPV). The company bills both commercial and government carriers without a standard CPT code. In this situation, many payers will outright deny claims and not overturn on appeal. Naveris is a specialty lab—the only one of its kind in the U.S.—that supplies specialty cancer detection tests to providers throughout the country. New technology for lab testing creates major disruptions in standard revenue cycle processes as unspecified CPT codes are often not accepted by many major payers. Fast-forward one year and the company is now submitting more than 5,000 claims with only three staff members, and that number is expected to quadruple in 2022. Kristina Steeneck, Head of

Join for free to read